Growth Metrics

Phibro Animal Health (PAHC) Long-Term Deferred Tax (2019 - 2026)

Phibro Animal Health has reported Long-Term Deferred Tax over the past 7 years, most recently at $19.5 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 42.29% year-over-year to $19.5 million; the TTM value through Dec 2025 reached $19.5 million, down 42.29%, while the annual FY2025 figure was $25.5 million, 31.89% up from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $19.5 million at Phibro Animal Health, down from $23.5 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $36.2 million in Q1 2025 and troughed at $4.1 million in Q1 2022.
  • A 5-year average of $14.7 million and a median of $9.7 million in 2021 define the central range for Long-Term Deferred Tax.
  • Biggest five-year swings in Long-Term Deferred Tax: tumbled 57.83% in 2021 and later soared 184.22% in 2024.
  • Year by year, Long-Term Deferred Tax stood at $8.2 million in 2021, then dropped by 22.91% to $6.3 million in 2022, then surged by 123.91% to $14.1 million in 2023, then soared by 139.16% to $33.8 million in 2024, then tumbled by 42.29% to $19.5 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for PAHC at $19.5 million in Q4 2025, $23.5 million in Q3 2025, and $25.5 million in Q2 2025.